Insider Transactions in Q4 2020 at Thermo Fisher Scientific Inc. (TMO)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 09
2020
|
Mark Stevenson Retiring Executive VP & COO |
BUY
Bona fide gift
|
Indirect |
15,960
+50.0%
|
-
|
Dec 09
2020
|
Mark Stevenson Retiring Executive VP & COO |
SELL
Bona fide gift
|
Indirect |
15,960
-8.53%
|
-
|
Dec 07
2020
|
Mark Stevenson Retiring Executive VP & COO |
SELL
Open market or private sale
|
Direct |
14,133
-20.87%
|
$6,684,909
$473.84 P/Share
|
Dec 07
2020
|
Mark Stevenson Retiring Executive VP & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,825
+26.03%
|
$3,073,425
$129.77 P/Share
|
Dec 04
2020
|
Mark Stevenson Retiring Executive VP & COO |
SELL
Open market or private sale
|
Direct |
14,113
-24.33%
|
$6,717,788
$476.46 P/Share
|
Dec 04
2020
|
Mark Stevenson Retiring Executive VP & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,825
+29.12%
|
$3,073,425
$129.77 P/Share
|
Dec 04
2020
|
Tyler Jacks Director |
SELL
Bona fide gift
|
Direct |
123
-1.76%
|
-
|
Nov 02
2020
|
Marc N Casper Chairman & CEO |
SELL
Open market or private sale
|
Indirect |
15,000
-21.64%
|
$7,260,000
$484.09 P/Share
|
Oct 27
2020
|
Marc N Casper Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-0.77%
|
$4,870,000
$487.54 P/Share
|
Oct 26
2020
|
Marc N Casper Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-1.1%
|
$4,800,000
$480.25 P/Share
|
Oct 23
2020
|
Peter E Hornstra VP & Chief Accounting Officer |
SELL
Bona fide gift
|
Indirect |
300
-1.86%
|
-
|
Oct 23
2020
|
Jim P Manzi Director |
SELL
Bona fide gift
|
Direct |
1,100
-5.79%
|
-
|
Oct 08
2020
|
Peter E Hornstra VP & Chief Accounting Officer |
BUY
Bona fide gift
|
Indirect |
33
+0.2%
|
-
|
Oct 08
2020
|
Peter E Hornstra VP & Chief Accounting Officer |
SELL
Bona fide gift
|
Direct |
33
-1.73%
|
-
|
Oct 01
2020
|
Peter E Hornstra VP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27
-0.15%
|
$11,826
$438.2 P/Share
|
Oct 01
2020
|
Peter E Hornstra VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60
+0.33%
|
-
|